Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia

Authors: Pryka R.1; Kowalsky S.; Haverstock D.

Source: Clinical Therapeutics, Volume 20, Number 1, January 1998 , pp. 141-155(15)

Publisher: Elsevier

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: ciprofloxacin 750 mg; lower respiratory tract infection; pneumonia; acute exacerbations of chronic bronchitis

Language: English

Document Type: Research article

DOI: 10.1016/S0149-2918(98)80041-6

Affiliations: 1: Bayer Corporation, Pharmaceutical Division, West Haven, Connecticut, U.S.A.

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A